Development and Evaluation of Fast Dissolving Oral Films of Mefenamic Acid for the Management of Fever
1, 1, 1, 1, 2, 1, 3, 1, 4
- 1College of Pharmaceutical Sciences, Government Medical College Kannur, Pariyaram, Kerala, INDIA.
- 2School of Pharmacy, Monash University Malaysia, Jalan Lagoon Selatan, Bandar Sunway, Selangor, MALAYSIA.
- 3College of Pharmacy, Sharjah University, Sharjah, UNITED ARAB EMIRATES.
- 4Sance Laboratories Pvt. Ltd., Pala, Kottayam, Kerala, INDIA.
CORRESPONDENCE
* Ms. Krishnameera Sajayan
College of Pharmaceutical Sciences, Government Medical College Kannur, Pariyaram–670 503, Kerala, INDIA.
Received: 17-10-2022; Accepted: 12-01-2023.
Volume 57, Issue 1s (Supplement) · pp. s41-s51 · 2023 · DOI: 10.5530/ijper.57.1s.6
ABSTRACT
The marketed formulations of Mefenamic Acid (MA) used for the treatment of fever in the paediatric population are reported to have several drawbacks. This study aimed to develop and evaluate the mefenamic acid–loaded oral dispersible films which may be a better alternative than the existing formulations. The solubility of mefenamic acid was enhanced by forming inclusion complexes with β cyclodextrin. The best ratio for the mefenamic acid-β cyclodextrin inclusion complex, 1:0.5 was selected based on the drug content and in vitro drug release. Fourier transform Infrared spectroscopy and scanning electron microscopy analysis was performed on the complex. The oral dispersible films were developed by solvent casting method and evaluated for parameters such as average weight, thickness, pH, folding endurance, percentage moisture uptake and loss, drug content, in vitro disintegration time and drug release. The statistical analysis of the data suggested that oral dispersible films with 4% w/v of crospovidone (coded P3) as the best. Drug content (95.46±0.93%), disintegration time (28.6±2.0 s), cumulative percentage drug release (97.41±0.68% in 180 s), and all other investigated parameters of P3 were well within the acceptable limit. The in vitro dissolution profile of P3 showed no significant difference from the marketed mefenamic acid suspension and has a good stability profile at in-house testing conditions. The data obtained from this investigation revealed that mefenamic acid oral dispersible films could act as an excellent alternative to existing marketed paediatric formulations.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Sajayan, K., KK, S., C, S. C., MC, J., Nair, R. S., K, S., Kappally, S., KR, S., & Joseph, J. (2023). Development and Evaluation of Fast Dissolving Oral Films of Mefenamic Acid for the Management of Fever. Indian Journal of Pharmaceutical Education and Research, 57(1s), s41-s51. https://doi.org/10.5530/ijper.57.1s.6
Copyright and licence
© 2023 Author(s)
This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited. CC BY 4.0